Amyotrophic lateral sclerosis (ALS), also known as 鈥淟ou Gehrig鈥檚 Disease,鈥 is a devastating fatal disease of the nervous system that kills two to five Canadians every day. On September 19th and 20th, the Montreal Neurological Institute and Hospital (The Neuro), at 平特五不中 and the 平特五不中 Health Centre will host the 10th Annual ALS Symposium of the Fondation Andr茅-Delambre. Nearly one hundred researchers and clinicians from several countries will come together to discuss recent progress in ALS research.
Dr. Peter McPherson, James 平特五不中 Professor of Neurology and Neurosurgery, and Anatomy and Cell Biology at the Montreal Neurological Institute, 平特五不中 has been named a Fellow of the Royal Society of Canada (RSC).
Dr. Alan Evans, a pioneering scientist who has helped map the human brain, has been awarded the Margolese National Brain Disorders Prize by the University of British Columbia. Dr. Evans is a researcher at the Montreal Neurological Institute and the James 平特五不中 Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering at 平特五不中.
Scientists at the Montreal Neurological Institute and Hospital, 平特五不中 and 平特五不中 Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes. Identifying SUMO鈥檚 role in the cancer cell growth will lead to a new strategy for glioblastoma treatment.
An international team of researchers has discovered a significant genetic component of Idiopathic Generalized Epilepsy (IGE), the most common form of epilepsy. Epilepsy is a neurological disorder characterized by sudden, uncontrolled electrical discharges in the brain expressed as a seizure. The new research, published in this week鈥檚 issue of EMBO Reports, implicates a mutation in the gene for a protein, known as cotransporter KCC2.听
Dr. Brenda Milner, an active researcher at the age of 95 at the Montreal Neurological Institute and Hospital - The Neuro, 平特五不中, is a recipient of The 2014 Kavli Prize in Neuroscience.
In a new study, published in this week鈥檚 issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli. In most neuroscience textbooks today, there is a widely held model that explains how nerve circuits might refine their connectivity based on patterned firing of brain cells, but it has not previously been directly observed in real time.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital -The Neuro, at 平特五不中 and 平特五不中 Health Centre, is being awarded the Prix d鈥檈xcellence 2014 by the Coll猫ge des m茅decins du Qu茅bec, for his outstanding contributions to neurogenetics and medicine. Dr. Rouleau accepts the award today at a ceremony at the Chateau Frontenac in Quebec City.
TRIBUTE VIDEO:
What鈥檚 new at The Neuro
Research: B cell study may lead to treatment options for MS
Dr. Michael Petrides is a co-recipient of one of only 24 Program Grants awarded worldwide by the Human Frontier Science Program, an international organization that supports new research in complex biological systems. Dr. Petrides is a researcher at the Montreal Neurological Institute and Hospital 鈥 The Neuro, as well as Professor in the Departments of Neurology and Neurosurgery, and Psychology at 平特五不中.
People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.
The Montreal Neurological Institute and Hospital - The Neuro, 平特五不中 and the 平特五不中 Health Centre, is at the forefront of Parkinson鈥檚 research and clinical care.听Parkinson鈥檚 patients are seen at The Neuro鈥檚 Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson鈥檚 disease.听听
New Rapid-Access Clinic at The Neuro reduces wait time
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The 鈥淢ontreal Procedure鈥 developed by Dr. Wilder Penfield and colleagues revolutionized the surgical treatment for epilepsy, allowing thousands of patients to start new lives free of seizures. The use of electroencephalography (EEG) and magnetic resonance imaging (MRI) for the study and treatment of epilepsy was pioneered at The Neuro.听
More than eighty researchers from France and Quebec met March 20 鈥 21, 2014 at the Montreal Neurological Institute and Hospital - The Neuro, 平特五不中 and the 平特五不中 Health Centre 鈥 for 听the second France-Quebec scientific workshop on amyotrophic lateral sclerosis (ALS) associated with frontotemporal dementia. The first edition was held in Paris in June 2012 at the Brain and Spine Institute (ICM). This meeting is co-organized by Professor Heather Durham (The Neuro) and Dr. Edor Kabashi (ICM).